Gordon Stein, CFO of CleanTech Lithium, explains why CTL acquired the 23 Laguna Verde licenses. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksIMI Regulatory News (IMI)

Share Price Information for IMI (IMI)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1,725.00
Bid: 1,726.00
Ask: 1,728.00
Change: -6.00 (-0.35%)
Spread: 2.00 (0.116%)
Open: 1,716.00
High: 1,737.00
Low: 1,707.00
Prev. Close: 1,731.00
IMI Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

IMI plc Interim Management Statement

9 Nov 2017 07:00

RNS Number : 9837V
IMI PLC
09 November 2017
 

9 November 2017

IMI plc Interim Management Statement

 

IMI, the specialist engineering company, issues the following Interim Management Statement, which covers the third quarter from 1 July to 30 September 2017. Unless otherwise indicated, comparatives reflect results on an organic constant currency basis.

Current trading and outlook

Progress with the Group's strategic initiatives continues and expectations for the year are slightly ahead of market estimates.

During the third quarter economic and market conditions have continued to be mixed. Organic revenues were 3% higher in the third quarter than the same period last year and, reflecting the benefit from foreign exchange movements, were 11% higher.

As previously indicated, organic revenues and margins in the second half are expected to improve when compared with the first half of 2017. Adjusted constant currency earnings per share for the full year are likely to be slightly ahead of the expectations outlined at the Group's 2017 interim results.

Strategic progress

Despite mixed market conditions, our various initiatives to harness the Group's potential continue to progress well. We remain committed to investment in new product development to fuel growth, improving operational performance to enhance our competitiveness and investing to modernise our IT infrastructure.

The business continues to successfully implement cost-reduction activities on time and on budget that support the near term financial results, whilst also supporting our long-term strategic agenda.

 

IMI Critical Engineering

In the nine months to September, Critical Engineering order intake was 4% higher than the previous year. In the third quarter, the expected 13% decline in orders included New Construction and Aftermarket which were 20% and 6% lower respectively, when compared with the same period last year. Parts orders were 1% higher in the period.

The value of the division's order book at the end of September 2017, at £544m, was 2% below the same point last year and includes £100m of orders won through Value Engineering, with margins now comparable to the prior year also reflecting an improved Aftermarket order book.

As expected, organic revenues were 4% lower year to date and in the three months to the end of September were 6% lower compared with the same period last year. On a reported basis revenues were 2% higher in the quarter.

As detailed in the Group's 2017 interim results, in the second half of the year, organic revenue is still expected to be weaker than the second half of last year. Full year margins are expected to show a modest improvement on 2016 - and a significant improvement on the first half of this year - due to the benefits of the division's reorganisation activities and phasing of the order backlog.

IMI Precision Engineering

Precision Engineering organic revenues in the three months to the end of September were 9% higher compared to the same period last year and on a reported basis were 18% higher.

Sales in Industrial Automation were 11% higher when compared to the third quarter of 2016, with growth across all three regions. Contrary to previous market expectations of continuing decline, Commercial Vehicle sales have been stronger in both Europe and North America. The Energy sector continued to be impacted by lower oil prices while both Life Sciences and Rail delivered growth in the quarter.

In the second half, on a constant currency basis, organic revenues and margins are expected to improve when compared with the second half of last year reflecting the benefits of ongoing cost reduction and improved market conditions.

IMI Hydronic Engineering

Hydronic Engineering organic revenues in the three months to the end of September were 3% higher compared to the same period last year and 12% higher on a reported basis.

Underlying conditions across our key European markets remain mixed and we continue to make good progress with new product development and operational improvements. Customer and market reaction to our market-leading new products continues to be positive.

In the second half, on a constant currency basis, we expect revenue growth to show some improvement when compared to the first half of the year. Margins will be slightly lower than the second half of last year due to increased costs associated with our investments for growth.

 

Exchange rates

As detailed in the Group's 2017 interim results, IMI's financial results are being favourably impacted by the effects of exchange rate movements compared to 2016, and in particular by the weakening of Sterling against the US Dollar and the Euro. At current rates, this would translate to an exchange rate tailwind for the full year of around 6% on both revenues and profits.

Preliminary results

IMI will issue its preliminary results announcement in respect of the year ending 31 December 2017 on 2 March 2018.

A conference call for analysts and investors will be held at 08:30 GMT today to discuss this statement. To access the call, please dial: +44 (0)1452 555 566, Toll Free (UK) 0800 694 0257- Conference call id: 2386128.

 

Enquiries to:

John Dean IMI Tel: +44 (0)121 717 3712

Suzanne Bartch / Teneo Blue Rubicon Tel: +44 (0)203 757 9239Gayden Metcalfe

 

Cautionary Statement:

This Interim Management Statement contains forward-looking statements which are made in good faith based on the information available at the time of its approval. It is believed that the expectations reflected in these statements are reasonable but they may be affected by a number of risks and uncertainties that are inherent in any forward-looking statement which could cause actual results to differ materially from those currently anticipated.

 

Notes to editors

IMI plc

IMI plc, the specialist engineering company, designs, manufactures and services highly engineered products that control the precise movement of fluids. IMI has manufacturing facilities in more than 20 countries and operates a global service network. The Company is listed on the London Stock Exchange. Further information is available at www.imiplc.com.

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
MSCFSMFAAFWSEDF
Date   Source Headline
12th Apr 20241:49 pmRNSDirector/PDMR Shareholding
10th Apr 20241:42 pmRNSDirector/PDMR Shareholding
2nd Apr 20241:50 pmRNSTotal Voting Rights
28th Mar 20249:11 amRNSAnnual Financial Report
27th Mar 20244:48 pmRNSDirector/PDMR Shareholding
20th Mar 202411:37 amRNSDirector/PDMR Shareholding
14th Mar 20248:58 amRNSRetail Investor Webinar
13th Mar 20241:58 pmRNSDirector/PDMR Shareholding
1st Mar 20241:58 pmRNSTotal Voting Rights
1st Mar 20241:57 pmRNSDirector Declaration
1st Mar 20247:00 amRNSPreliminary Results
29th Feb 202410:09 amRNSDirectorate Change
27th Feb 20248:54 amRNSHolding(s) in Company
14th Feb 202411:35 amRNSDirector/PDMR Shareholding
1st Feb 202411:28 amRNSTotal Voting Rights
30th Jan 202411:02 amRNSDirectorate Change
10th Jan 20241:01 pmRNSDirector/PDMR Shareholding
2nd Jan 202411:35 amRNSBlock listing Interim Review
2nd Jan 202411:04 amRNSTotal Voting Rights
19th Dec 20239:55 amRNSDirector/PDMR Shareholding
13th Dec 20233:41 pmRNSDirector/PDMR Shareholding
5th Dec 20239:28 amRNSDirector Declaration
1st Dec 20231:30 pmRNSTotal Voting Rights
15th Nov 20231:42 pmRNSDirector/PDMR Shareholding
9th Nov 20237:01 amRNSHistorical Financial Information
9th Nov 20237:00 amRNSInterim Management Statement
1st Nov 202312:42 pmRNSTotal Voting Rights
11th Oct 20233:20 pmRNSDirector/PDMR Shareholding
2nd Oct 20231:19 pmRNSTotal Voting Rights
13th Sep 20233:32 pmRNSDirector/PDMR Shareholding
1st Sep 202311:29 amRNSTotal Voting Rights
10th Aug 20234:53 pmRNSDirector/PDMR Shareholding
10th Aug 20234:38 pmRNSDirector/PDMR Shareholding
9th Aug 20232:34 pmRNSDirector/PDMR Shareholding
1st Aug 202310:16 amRNSTotal Voting Rights
31st Jul 20231:52 pmRNSDirector/PDMR Shareholding
28th Jul 20237:00 amRNSInterim Results
12th Jul 20231:13 pmRNSDirector/PDMR Shareholding
3rd Jul 20232:58 pmRNSBlock listing Interim Review
3rd Jul 20232:41 pmRNSTotal Voting Rights
26th Jun 20234:39 pmRNSHolding(s) in Company
14th Jun 202310:48 amRNSDirector/PDMR Shareholding
8th Jun 20233:18 pmRNSDirector/PDMR Shareholding
1st Jun 20231:51 pmRNSTotal Voting Rights
22nd May 202310:18 amRNSDirectorate Change
11th May 202311:49 amRNSHolding(s) in Company
10th May 20232:40 pmRNSDirector/PDMR Shareholding
4th May 20231:05 pmRNSResult of AGM
4th May 20237:00 amRNSInterim Management Statement
2nd May 20232:46 pmRNSTotal Voting Rights

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.